Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

NCT01370096 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01370096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01370096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2012
Completion date
September 30, 2016
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension